NCT04476303View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics and Safety of BEY2153 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

August 27, 2020

Primary Completion Date

November 23, 2021

Study Completion Date

November 23, 2021

Conditions
Alzheimer's Disease
Interventions
DRUG

BEY2153

Capsule

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

BeyondBio Inc.

INDUSTRY

NCT04476303 - A Study to Evaluate the Pharmacokinetics and Safety of BEY2153 in Healthy Participants | Biotech Hunter | Biotech Hunter